GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shire PLC (NAS:SHPG) » Definitions » Piotroski F-Score

Shire (SHPG) Piotroski F-Score : 0 (As of Apr. 25, 2024)


View and export this data going back to 1998. Start your Free Trial

What is Shire Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Shire has an F-score of 6 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Shire's Piotroski F-Score or its related term are showing as below:


Shire Piotroski F-Score Historical Data

The historical data trend for Shire's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shire Piotroski F-Score Chart

Shire Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.00 7.00 4.00 5.00 7.00

Shire Quarterly Data
Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.00 7.00 7.00 6.00 6.00

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep18) TTM:Last Year (Sep17) TTM:
Net Income was 3105.4 + 550.6 + 615.5 + 537.2 = $4,809 Mil.
Cash Flow from Operations was 1519.6 + 1010.3 + 939.6 + 857.6 = $4,327 Mil.
Revenue was 4144.9 + 3765.7 + 3919.5 + 3871.7 = $15,702 Mil.
Gross Profit was 2881.4 + 2633.3 + 2811.2 + 2714.1 = $11,040 Mil.
Average Total Assets from the begining of this year (Sep17)
to the end of this year (Sep18) was
(67476.5 + 67756.9 + 67868.8 + 66222.1 + 63765.9) / 5 = $66618.04 Mil.
Total Assets at the begining of this year (Sep17) was $67,477 Mil.
Long-Term Debt & Capital Lease Obligation was $11,098 Mil.
Total Current Assets was $7,799 Mil.
Total Current Liabilities was $8,512 Mil.
Net Income was 457.3 + 375 + 240.3 + 550.8 = $1,623 Mil.

Revenue was 3806.1 + 3572.3 + 3745.8 + 3697.6 = $14,822 Mil.
Gross Profit was 2752.5 + 2245.3 + 2636.9 + 2696.2 = $10,331 Mil.
Average Total Assets from the begining of last year (Sep16)
to the end of last year (Sep17) was
(69751.3 + 67035.4 + 66160.1 + 67190.9 + 67476.5) / 5 = $67522.84 Mil.
Total Assets at the begining of last year (Sep16) was $69,751 Mil.
Long-Term Debt & Capital Lease Obligation was $17,956 Mil.
Total Current Assets was $7,292 Mil.
Total Current Liabilities was $7,461 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Shire's current Net Income (TTM) was 4,809. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Shire's current Cash Flow from Operations (TTM) was 4,327. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Sep17)
=4808.7/67476.5
=0.07126481

ROA (Last Year)=Net Income/Total Assets (Sep16)
=1623.4/69751.3
=0.02327412

Shire's return on assets of this year was 0.07126481. Shire's return on assets of last year was 0.02327412. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Shire's current Net Income (TTM) was 4,809. Shire's current Cash Flow from Operations (TTM) was 4,327. ==> 4,327 <= 4,809 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Sep18)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep17 to Sep18
=11098/66618.04
=0.16659151

Gearing (Last Year: Sep17)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep16 to Sep17
=17956/67522.84
=0.26592483

Shire's gearing of this year was 0.16659151. Shire's gearing of last year was 0.26592483. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Sep18)=Total Current Assets/Total Current Liabilities
=7799.3/8511.6
=0.91631421

Current Ratio (Last Year: Sep17)=Total Current Assets/Total Current Liabilities
=7291.5/7461.1
=0.97726877

Shire's current ratio of this year was 0.91631421. Shire's current ratio of last year was 0.97726877. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Shire's number of shares in issue this year was 307.033. Shire's number of shares in issue last year was 303.867. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=11040/15701.8
=0.7031041

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=10330.9/14821.8
=0.69700711

Shire's gross margin of this year was 0.7031041. Shire's gross margin of last year was 0.69700711. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Sep17)
=15701.8/67476.5
=0.23270027

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Sep16)
=14821.8/69751.3
=0.21249496

Shire's asset turnover of this year was 0.23270027. Shire's asset turnover of last year was 0.21249496. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+0+1+0+0+1+1
=6

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Shire has an F-score of 6 indicating the company's financial situation is typical for a stable company.

Shire  (NAS:SHPG) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Shire Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Shire's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Shire (SHPG) Business Description

Traded in Other Exchanges
N/A
Address
Shire is a diversified, Ireland-based specialty drug firm. Shire has grown primarily through mergers and acquisitions, including the Transkaryotic Therapies acquisition in 2005, which established its genetic disease business with Replagal and Elaprase, and the merger with New River in 2007, which brought full rights to neuroscience drug Vyvanse. Shire completed the acquisition of ViroPharma (genetic diseases) in 2014, NPS Pharma (internal medicine) in 2015, and Baxalta (hematology, immunology, and oncology) and Dyax (genetic diseases) in 2016.
Executives
James H Cavanaugh director 265 HOTHORPE LANE, VILLANOVA PA 19085

Shire (SHPG) Headlines

From GuruFocus

Chris Davis' Top 3 Buys of the 1st Quarter

By James Li James Li 05-14-2018

Shire Completes Sale of Oncology Franchise

By Marketwired Marketwired 08-31-2018